Congratulations to Dr. Nate Shannon on his recently published manuscript! Lots of exciting findings to follow up on related to Miro1 and mitochondrial positioning. journals.biologists.com/jcs/article/do…
English
Cunniff Lab
170 posts
Cunniff Lab
@CunniffLab
The Cunniff lab is interested in how mitochondrial dynamics influence cell processes and is identifying new therapeutics targets for aggressive cancers.
Entrou em Temmuz 2019
121 Seguindo148 Seguidores
Some good news (and fresh science) to break things up! Our work identifying a subpopulation of compositionally unique mitochondria that localize to filopodia and promote cell migration is now online @CurrentBiology! Led by fantastic @madeleinemarlar!
cell.com/current-biolog…
English
It's a pleasure to share the first manuscript from my lab! biorxiv.org/content/10.110…
English
Congrats to Nate on an excellent thesis!
UVM Larner Med@UVMLarnerMed
Congrats Nathaniel Shannon, #UVMLarnerMed CMB graduate Ph.D. candidate, who successfully defended his dissertation, “The Role Of Miro1 Mediated Mitochondrial Positioning On Redox...” Pictured (left) w/ advisor @BrianCunniff, Ph.D. @CunniffLab @UVMResearch @uvmcmb @UVMGradCollege
English
Come check out PhD candidate Victoria Gibson discuss the importance of Peroxiredoxin 3 in mesothelioma tumors at #SfRBM2024. SYMPOSIA SESSION 3: Unveiling the Therapeutic Potential: Exploring Redox Signaling from Fundamentals to Drug Targets 2:45pm @RedoxVT @RSOncologyLLC @SFRBM
English
PhD Candidate Nate Shannon's first author paper out as a pre-print. Very proud of Nate! Some very interesting DEGs dependent on Miro1 expression and an interesting and evolving cell cycle/ERK1/2 story! @UVMcancercenter @RedoxVT #mitochondria
biorxiv.org/content/10.110…
English
English
As the newest arrival on campus, @wakeforestmed and @WakeCancer will not disappoint! Come join us!
Steven Kridel, PhD ❎@KridelSteven
The Department of Cancer Biology at @wakeforestmed @WakeCancer is hiring! TT Assistant Professor in #metabolism, #microbiome, or diet cancer interactions. See link or DM for info. Come beat cancer with us! Please share & RT! jobs.sciencecareers.org/job/660149/ten…
English
English
I am thrilled and honored to join the @HHMINEWS community. So grateful to my lab, colleagues at @DanaFarber @HarvardCellBio, and collaborators whose work this reflects!
English
Cunniff Lab retweetou
UVM Cancer Center@UVMcancercenter
NEW @NatureCellBio study finds glutathione S transferase theta drives pancreatic cancer metastasis by targeting fibronectin which places redox reactions front and center in tumor metastatic behavior. Congrats @RedoxVT on supporting these findings! go.nature.com/4aVXWAE
English
Excited to see Dean present exciting data around the Phase 1 trial of RSO-021 at #ASCO24. A redox-dependent cancer therapy currently being tested in Phase 2! @RedoxVT @UVMcancercenter @dean_fennell @RSOncologyLLC x.com/RSOncologyLLC/…
English
Cunniff Lab retweetou
#ASCO24 Abstracts have been published! See the short list of rapid oral abstracts in Developmental Therapeutics - Molecularly Targeted Agents & Tumor Biology and you will see our first-in-human phase 1 for RSO-021 @dean_fennell @CunniffLab @PRCLeicester
tinyurl.com/ASCO24
English
Congrats to @RSOncologyLLC for this much deserved recognition at #ASCO24 . Looking forward to @dean_fennell giving and exciting talk! @RedoxVT
RS Oncology@RSOncologyLLC
RSO-021 novel therapy and first-in-human clinical trial outcomes🫁will be presented on June 3rd at #ASCO24 with @dean_fennell #CancerResearch @BrianCunniff @UVMcancercenter finance.yahoo.com/news/rs-oncolo…
English
Always an excellent meeting with great science and clinical progress being showcased! @RedoxVT @UVMcancercenter @RSOncologyLLC
RS Oncology@RSOncologyLLC
Sharing our 🔬scientific findings and preclinical data🫁. If you are at #AACR24 #SanDiego stop by today to see our presentation ~ @9am_today Titled: First-in-class peroxiredoxin 3 (PRX3) inhibitor RSO-021 triggers mesenchymal-to-epithelial transition in #meso. #taketwo
English
Looking forward to presenting our new data in support of the anti-cancer activity of RSO-021, lots of fresh discoveries! @RedoxVT @dean_fennell @UVMcancercenter
RS Oncology@RSOncologyLLC
Gearing up for #SanDiego next month. But you won't find us on the beach April 7th or 9th, since we will be presenting our posters at @AACR 2024. Add us to your itinerary to see our 🐭preclinical anticancer activity #Mesothelioma #CancerResearch @BrianCunniff @dean_fennell
English
Cunniff Lab retweetou
Happy to announce our abstract has been approved 👏👏 #BTOG24 Our CSO Brian Cunniff, Phd, @CunniffLab will be presenting "First-in-class peroxiredoxin 3 (PRX3) inhibitors" poster. Stop by the welcome reception Wednesday April 17th, 18:30 – 20:00, say hello or ask questions.
GIF
English
Cunniff Lab retweetou
Happy to share our review with @echouchani on recent advances in cysteine proteomics! @HarvardCellBio @DFCI_CancerBio
authors.elsevier.com/c/1idmT4sz6MMd…
English